US4396713A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Restriction endonuclease fingerprinting of kinetoplast DNA minicircles
Assignee: University of California
•
Filing: 1980-11-12
•
Granted: 1983-08-02
•
Expires: 2000-11-12
Abstract
Abstract Hemoflagellates are characterized by restriction endonuclease digestion of the mitochondrial DNA to provide for substantial cleavage of the kDNA network. The resulting electrophoretic profile of the digest can be used as a restriction fingerprint for distinguishing organisms and specific strains. The kDNA is found to be sufficiently stable through numerous passages of the organism to provide a reliable fingerprint.
Inventors
- 👤 Larry P. Simpson
- 👤 Carlos M. Morel
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-01 07:04
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6813; C12Q1/6827; C12Q1/683; C12Q1/6876; C12Q1/6888; C12Q1/6893; Y; Y02; Y02A; Y02A50/00; Y02A50/30; Y10; Y10S; Y10S435/00; Y10S435/803; Y10S435/81
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
137 words
A method for assaying for the presence in a sample of a stock or strain within a species of hemoflagellate which comprises: isolating kDNA from a cell culture from said sample; restriction endonuclease digesting said isolated kDNA with at least one restriction endonuclease selected from the group consisting of EcoRI, HaeIII, HinfI, MspI, and TaqI to provide for cleavage of minicircles present in said kDNA, wherein at least 20% of the minicircles are cleaved at least twice; electrophoresing the digested kDNA under conditions of high resolution to provide a schizodeme profile unique to a particular hemoflagellate strain or stock; and comparing said profile with a known hemoflagellate strain or stock digested and electrophoresed in substantially the same manner as said kDNA from said sample cell culture to determine the presence of said known hemoflagellate in said sample.
Claim 2
Independent Claim
137 words
A method for assaying for the presence in a sample of a stock or strain within a species of hemoflagellate which comprises: isolating kDNA from a cell culture from said sample; restriction endonuclease digesting said isolated kDNA with at least one restriction endonuclease selected from the group consisting of EcoRI, HaeIII, HinfI, MspI, and TaqI to provide for cleavage of minicircles present in said kDNA, wherein at least 20% of the minicircles are cleaved at least twice; electrophoresing the digested kDNA under conditions of high resolution to provide a schizodeme profile unique to a particular hemoflagellate strain or stock; and comparing said profile with a known hemoflagellate strain or stock digested and electrophoresed in substantially the same manner as said kDNA from said sample cell culture to determine the presence of said known hemoflagellate in said sample.
Claim 3
Dependent Claim
16 words
A method according to claim 1, wherein said high resolution employs a linear gradient polyacrylamide gel.
Claim 4
Independent Claim
16 words
A method according to claims 1 or 2, where one of said restriction enzymes is TaqI.
Claim 5
Independent Claim
15 words
A method according to claims 1, or 2, where one of said enzymes is EcoRI.
Claim 6
Dependent Claim
12 words
A method according to claim 1, where said hemoflagellate is a trypanosome.
Claim 7
Independent Claim
161 words
A method for assaying for the presence in a sample of a Kinetoplastida strain, which comprises: growing microorganisms in a nutrient medium from a sample suspected of containing Kinetoplastida; lysing the cells and isolating the cells by means of centrifugation to provide a pellet; suspending the pellet in an aqueous buffered medium and extracting said medium with at least one organic solvent; digesting the kDNA with at least one restriction endonuclease selected from the group consisting of EcoRI, HaeIII, HinfI, MspI, and TaqI to cleave at least a substantial proportion of the minicircles present in said kDNA and at least 20% of said minicircles twice; electrophoresing said digested kDNA under high resolution conditions to provide a profile characteristic of a particular Kinetoplastida strain; and comparing said profile with a known hemoflagellate strain or stock digested and electrophoresed in substantially the same manner as said kDNA from said sample cell culture to determine the presence of said known hemoflagellate in said sample.
Claim 8
Independent Claim
161 words
A method for assaying for the presence in a sample of a Kinetoplastida strain, which comprises: growing microorganisms in a nutrient medium from a sample suspected of containing Kinetoplastida; lysing the cells and isolating the cells by means of centrifugation to provide a pellet; suspending the pellet in an aqueous buffered medium and extracting said medium with at least one organic solvent; digesting the kDNA with at least one restriction endonuclease selected from the group consisting of EcoRI, HaeIII, HinfI, MspI, and TaqI to cleave at least a substantial proportion of the minicircles present in said kDNA and at least 20% of said minicircles twice; electrophoresing said digested kDNA under high resolution conditions to provide a profile characteristic of a particular Kinetoplastida strain; and comparing said profile with a known hemoflagellate strain or stock digested and electrophoresed in substantially the same manner as said kDNA from said sample cell culture to determine the presence of said known hemoflagellate in said sample.
Claim 9
Dependent Claim
12 words
A method according to claim 6, wherein said Kinetoplastida is a Trypanosoma.
Claim 10
Dependent Claim
11 words
A method according to claim 6, wherein said Kinetoplastida is Leishmania.
Claim 11
Independent Claim
14 words
A method according to claims 6, 7 or 8, wherein said digestion employs TaqI.
Claim 12
Dependent Claim
15 words
A method according to claim 9, wherein said electrophoresing employs a linear gradient polyacrylamide gel.
Claim 13
Dependent Claim
18 words
A method according to claim 10, wherein said lysing is achieved with pronase in the presence of sarkosinate.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1986-08-01 | 1987-01-31 | 1987-08-02 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1990-08-01 | 1991-01-31 | 1991-08-02 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1994-08-01 | 1995-01-31 | 1995-08-02 | $7700.00 | Window Closed / Lapsed |